Positive correlations between CD40‐expressing DC subsets were lost in patients, and negative correlations between CD80‐expressing DCs and CD86+ pDCs emerged in tumor infiltrates, which fits with impacts observed on clinical outcomes (Figure 2b, Supplementary figure 3f). This evidence concerns the gene CD86 and neoplasm.